Vimta Labs Posts ₹1.09 Billion Revenue In March Quarter With Strong Operational Growth

Hyderabad-based Vimta Labs, a leading contract research and testing services company, has announced its March quarter results, showcasing steady growth in revenue and profitability. The dividend recommendation underlines its commitment to shareholder value while reinforcing its position in India’s life sciences and testing industry.

Quarterly Performance

Revenue from operations stood at ₹1.09 billion, supported by strong demand across pharmaceutical, food, and environmental testing services. Profit from continuing operations reached ₹211.1 million, highlighting efficient cost management and operational resilience.

Dividend Declaration

The board has recommended a dividend of ₹2 per share for FY2025-26. This move signals confidence in the company’s cash flows and long-term growth trajectory, rewarding shareholders for their continued support.

Market Outlook

With increasing demand for specialized testing and research services, Vimta Labs is well-positioned to capitalize on opportunities in pharmaceuticals, biotechnology, and food safety. The company’s focus on innovation and compliance continues to strengthen its competitive edge in both domestic and international markets.

Key Highlights

• March quarter revenue from operations: ₹1.09 billion
• Profit from continuing operations: ₹211.1 million
• Dividend recommended: ₹2 per share
• Strong demand across pharma, food, and environmental testing services
• Positioned for growth in life sciences and research markets

Sources: Business Standard, Moneycontrol, Economic Times, Mint